MediWound (MDWD) Total Non-Current Liabilities (2013 - 2025)
MediWound's (MDWD) quarterly Total Non-Current Liabilities came in at $16.9 million in Q4 2025, up 7.04% year-on-year from $15.8 million in Q4 2024, and down 6.1% quarter-over-quarter from $18.0 million in Q3 2025.
MediWound (MDWD) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends
MediWound's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $16.9 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 7.04% year-over-year to $16.9 million in Q4 2025; TTM through Dec 2025 was $16.9 million, a 7.04% increase from a year earlier, with the FY2025 full-year figure at $16.9 million, up 7.04% from the prior year.
- Total Non-Current Liabilities fell to $16.9 million in Q4 2025 per MDWD's latest filing, from $18.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $27.0 million in Q4 2022 and bottomed at $11.4 million in Q1 2023.
- The 5-year median for Total Non-Current Liabilities is $15.9 million (2024), against an average of $15.8 million.
- Across the five-year window, Total Non-Current Liabilities soared 98.79% in 2022 and slumped 38.11% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $13.6 million in 2021, then surged by 98.79% to $27.0 million in 2022, then plunged by 38.11% to $16.7 million in 2023, then declined by 5.6% to $15.8 million in 2024, then advanced by 7.04% to $16.9 million in 2025.
- Per Business Quant, the three latest MDWD Total Non-Current Liabilities figures stand at $16.9 million (Q4 2025), $18.0 million (Q3 2025), and $17.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | 16.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.92 Mn |
| Sep 30, 2025 | 18.01 Mn |
| Jun 30, 2025 | 17.81 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 15.80 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 16.82 Mn |
| Mar 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 16.74 Mn |
| Sep 30, 2023 | 16.63 Mn |
| Jun 30, 2023 | 11.45 Mn |
| Mar 31, 2023 | 11.43 Mn |
| Dec 31, 2022 | 27.05 Mn |
| Sep 30, 2022 | 17.92 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 14.03 Mn |
| Jun 30, 2021 | 14.43 Mn |
| Mar 31, 2021 | 14.56 Mn |